Henry J Binder Selected Research

Resistant Starch

1/2010	Role of colonic short-chain fatty acid transport in diarrhea.
2/2008	A randomized controlled trial of glucose versus amylase resistant starch hypo-osmolar oral rehydration solution for adult acute dehydrating diarrhea.
4/2006	Amylase-resistant starch as adjunct to oral rehydration therapy in children with diarrhea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry J Binder Research Topics

Disease

17	Diarrhea 01/2020 - 03/2004
4	Dehydration (Water Stress) 03/2014 - 04/2006
2	Inflammation (Inflammations) 10/2015 - 03/2004
2	Colitis 10/2015 - 03/2004
2	Cholera 02/2008 - 04/2006
1	Acidosis 05/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2014
1	Nausea 08/2011
1	Vomiting 08/2011
1	Infections 04/2008
1	Adenoma (Adenomas) 06/2007
1	Hyponatremia 11/2006
1	Kidney Calculi (Kidney Stone) 04/2006
1	Urolithiasis 04/2006
1	Hyperoxaluria (Oxaluria) 04/2006
1	Colonic Pseudo-Obstruction (Ogilvie Syndrome) 10/2005
1	Hyperplasia 03/2004

Drug/Important Bio-Agent (IBA)

6	SolutionsIBA 04/2014 - 04/2006
6	ORALIT (ORS)IBA 04/2014 - 04/2006
4	AnionsIBA 08/2011 - 05/2005
3	ZincIBA 01/2017 - 06/2006
3	SodiumIBA 04/2014 - 10/2005
3	Glucose (Dextrose)FDA LinkGeneric 04/2014 - 04/2006
3	Amylases FDA Link 01/2010 - 04/2006
3	Resistant StarchIBA 01/2010 - 04/2006
2	Protein Isoforms (Isoforms)IBA 10/2015 - 06/2007
2	SecretagoguesIBA 05/2015 - 08/2011
2	ElectrolytesIBA 08/2011 - 02/2008
2	ChloridesIBA 08/2011 - 10/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2010 - 02/2008
2	Starch (Cornstarch)IBA 01/2010 - 02/2008
2	Volatile Fatty AcidsIBA 01/2010 - 04/2006
2	Proteins (Proteins, Gene)FDA Link 06/2007 - 03/2004
1	Pharmaceutical PreparationsIBA 01/2017
1	Dextran SulfateIBA 10/2015
1	3-methylsulfonyl-4-piperidinobenzoyl guanidineIBA 10/2015
1	3- (2- (3- guanidino- 2- methyl- 3- oxo- propenyl)- 5- methylphenyl)- N- isopropylidene- 2- methyl- acrylamide dihydrochlorideIBA 10/2015
1	Butyrates (Butyrate)IBA 10/2015
1	Phenobarbital (Luminal)FDA Link 10/2015
1	Sodium-Hydrogen ExchangersIBA 10/2015
1	Complement System Proteins (Complement)IBA 10/2014
1	Bicarbonates (Hydrogen Carbonate)IBA 08/2011
1	Cyclic AMP (AMP, Cyclic)IBA 01/2010
1	CarbohydratesIBA 01/2010
1	AmyloseIBA 02/2008
1	Messenger RNA (mRNA)IBA 06/2007
1	4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA 06/2007
1	hydroxide ionIBA 06/2007
1	Calcium OxalateIBA 04/2006
1	OxalatesIBA 04/2006
1	PotassiumIBA 10/2005
1	SaltsIBA 10/2005
1	MicronutrientsIBA 05/2005
1	Trace Elements (Biometals)IBA 05/2005
1	Keratin-8 (Keratin 8)IBA 03/2004
1	Keratins (Keratin)IBA 03/2004

Therapy/Procedure

8	Fluid Therapy (Oral Rehydration Therapy) 01/2020 - 04/2006
4	Therapeutics 10/2014 - 02/2008
1	Secondary Prevention 10/2014
1	Drug Therapy (Chemotherapy) 03/2012